Biomedical Engineering Reference
In-Depth Information
24. Huang X, Senatore A, Dawson TF et al (2010) G-proteins modulate invertebrate synaptic
calcium channel (LCa(v)2) differently from the classical voltage-dependent regulation of
mammalian Ca(v)2.1 and Ca(v)2.2 channels. J Exp Biol 15:2094-2103
25. Goodman MB (2003) Sensation is painless. Trends Neurosci 26:643-645
26. Bell TJ, Thaler C, Castiglioni AJ et al (2004) Cell specific alternative splicing increases
calcium channel current density in the pain pathway. Neuron 41:127-138
27. Van PF, Minor DL (2006) The structural biology of voltage-gated calcium channel function
and regulation. Biochem Soc Trans 34:887-893
28. Catterall WA, Striessnig J, Snutch TP et al (2003) International Union of Pharmacology XL.
Compendium of voltage-gated ion channels: calcium channels. Pharmacol Rev 55:579-581
29. Catterall WA (2000) Structure and regulation of Voltage-gated Ca
2+
channels. Annu Rev Cell
Dev Biol 16:521-555
30. Ertel EA, Campbell KP, Harpold MM et al (2000) Nomenclature of voltage-gated calcium
channels. Neuron 25:533-535
31. Catterall WA, Perez-Reyes E, Snutch TP et al (2005) International union of pharmacology
XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium
channels. Pharmacol Rev 57:411-425
32. Cao Yu-Qing (2006) Voltage-gated calcium channels and pain. Pain 126:5-9
33. Moosmang S, Lenhardt P, Haider N et al (2005) Mouse models to study L-type calcium
channel function. Pharmacol Ther 106:347-355
34. Dolphin AC (2006) A short history of voltage-gated calcium channels. Br J Pharmacol 147:
S56-S62
35. Chen YH, Li MH, Zhang Y et al (2004) Structural basis of the
a
1
-
b
subunit interaction of
voltage-gated Ca
2+
channels. Nature 429:675-680
36. Lin-ling H, Yun Z, Yu-hang C et al (2007) Functional modularity of the
-subunit of voltage-
b
gated Ca
2+
channels. Biophys J 93:834-845
37. McGivern JG, McDonough SI (2004) Voltage-gated calcium channels as targets for the
treatment of chronic pain. Curr Drug Targets CNS Neurol Disord 3:457-478
38. Matthews EA, Dickenson AH (2001) Effects of spinally delivered N- and P-type voltage-
dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of
neuropathy. Pain 92:235-246
39. Takahashi E, Tan-No K, Tadano T (2010) Behavioral and neurochemical characterization of
mice deficient in the N-type Ca
2+
channel
1B
subunit. Behav Brain Res 208:224-230
40. Bowersox SS, Luther R (1998) Pharmacotherapeutic potential of omega-conotoxin MVIIA
(SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus.
Toxicon 36:1651-1658
41. Bowersox SS, Gadbois T, Singh T et al (1996) Selective N-type neuronal voltage-sensitive
calcium channel blocker, SNX-111, produces spinal anti-nociception in rat models of acute,
persistent and neuropathic pain. J Pharmacol Exp Ther 279:1243-1249
42. Schmidtko A, Lotsch J, Freynhagen R et al (2010) Ziconotide for treatment of severe chronic
pain. Lancet 375:1569-1577
43. Scott DA, Wright CE, Angus JA (2002) Actions of intrathecal omega-conotoxins CVID,
GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol
451:279-286
44. Vega-Hern
ยด
ndez A, Felix R (2002) Down-regulation of N-type voltage-activated Ca
2+
channels by gabapentin. Cell Mol Neurobiol 22:185-190
45. Field MJ, Hughes J, Singh L (2000) Further evidence for the role of the
a
2
d
a
subunit of voltage
dependent calcium channels in models of neuropathic pain. Br J Pharmacol 131:282-286
46. Snutch TP (2001) Substituted piperazine and piperidine calcium channel blockers. WO
01045709
47. Snutch TP (2006) Composition comprising a combination of a nonpeptidyl N-type calcium
channel blocker and a second compound e.g. opioid-useful for ameliorating pain. WO
06105670
